Synchronized Total Dose Behavior and Override Support for Custom and Trial Unit Dose Drugs in Chemotherapy Manager

What’s New

• Synchronized total dose behavior: Total dose behavior for Custom and Trial Drugs is now fully synchronized with normal drugs, ensuring consistent functionality across all drug types.
• Total dose override support: Custom and trial drugs configured with unit-based dosing now support overriding the calculated total dose.
• The system-calculated total dose appears as a clickable hyperlink in draft chemotherapy plans.
• Providers can override the calculated total dose and optionally enter or select a reason for the override.
• The originally prescribed unit dose remains unchanged.
• Overridden doses are clearly reflected in reports and audit logs.
• Flat dose drugs remain non-editable and do not display a clickable total dose.

How It Works 

1. Open a draft chemotherapy plan in Chemotherapy Manager.

2. Add either a custom drug or a trial drug configured with unit-based dosing (e.g., mg/m²).
3. The system automatically calculates the total dose.
4. The calculated total dose appears as a clickable hyperlink.
5. Click the hyperlink to override the total dose.
6. Enter or select a reason for the override (optional).
7. Save the draft plan.

If a total dose is overridden:

• The originally ordered unit dose (e.g., mg/m²) remains unchanged as prescribed by the physician.

• “Dose Overridden by Physician” text appears next to the total dose.

• The Chemo plan report clearly reflects that the dose has been overridden.

• The drug details screen logs the complete override transaction for audit and traceability purposes.

This functionality applies only to non-flat unit dose configurations.

Benefits

• Provides consistent total dose behavior across normal, custom, and trial drugs.
• Offers clinical flexibility for dose adjustments when required.
• Maintains integrity of the prescribed unit dose.
• Preserves transparency through detailed reporting and audit tracking.
• Enhances consistency and usability in chemotherapy planning workflows.